Use of known agonists of the central cannabinoid receptor CB1

US6284788A · kind A · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Joachim Mittendorf · Wuppertal, DE
• Jurgen Dressel · Radevormwald, DE
• Michael Matzke · Wuppertal, DE
• Jürgen Franz · Haan, DE
• Peter Spreyer · Düsseldorf, DE
• Verena Vöhringer · Wuppertal, DE
• Joachim Schuhmacher · Wuppertal, DE
• Arno Friedl · Bensberg, DE
• Ervin Horvath · Leverkusen, DE
• Frank Mauler · Overath, DE
• Jean De Vry · Stolberg, DE
• Reinhard Jork · Haan, DE

Key dates

• Filing date: Feb 17, 1998
• Grant date: Sep 4, 2001
• Expiry date: Feb 17, 2018

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P25/28
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to the use of known agonists of the central cannabinoid receptor CB1 for the prophylaxis and treatment of neurodegenerative disorders, in particular for the treatment of cerebral apoplexy and craniocerebral trauma.